Search Results - Kenneth W. Bayles

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Contribution of the Staphylococcus aureus Atl AM and GL murein hydrolase activities in cell division, autolysis, and biofilm formation. by Jeffrey L Bose, McKenzie K Lehman, Paul D Fey, Kenneth W Bayles

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  2. 2

    Epithelial Cell Gene Expression Induced by Intracellular Staphylococcus aureus by Xianglu Li, William G. Fusco, Keun S. Seo, Kenneth W. Bayles, Erin E. Mosley, Mark A. McGuire, Gregory A. Bohach

    Published in International Journal of Microbiology (2009-01-01)
    Get full text
    Article


  3. 3

    CcpA regulates arginine biosynthesis in Staphylococcus aureus through repression of proline catabolism. by Austin S Nuxoll, Steven M Halouska, Marat R Sadykov, Mark L Hanke, Kenneth W Bayles, Tammy Kielian, Robert Powers, Paul D Fey

    Published in PLoS Pathogens (2012-01-01)
    Get full text
    Article


  4. 4

    A thermodynamic bottleneck in the TCA cycle contributes to acetate overflow in Staphylococcus aureus by Nabia Shahreen, Jongsam Ahn, Adil Alsiyabi, Niaz Bahar Chowdhury, Dhananjay Shinde, Sujata S. Chaudhari, Kenneth W. Bayles, Vinai C. Thomas, Rajib Saha

    Published in mSphere (2025-01-01)
    Get full text
    Article


  5. 5

    Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. by Karen E Beenken, Lara N Mrak, Linda M Griffin, Agnieszka K Zielinska, Lindsey N Shaw, Kelly C Rice, Alexander R Horswill, Kenneth W Bayles, Mark S Smeltzer

    Published in PLoS ONE (2010-05-01)
    Get full text
    Article


  6. 6

    Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria by Jason M. Roe, Kevin Seely, Caleb J. Bussard, Emily Eischen Martin, Elizabeth G. Mouw, Kenneth W. Bayles, Michael A. Hollingsworth, Amanda E. Brooks, Kaitlin M. Dailey

    Published in Pharmaceutics (2023-07-01)
    Get full text
    Article


  7. 7

    An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic by Kaitlin M. Dailey, James M. Small, Jessica E. Pullan, Seth Winfree, Krysten E. Vance, Megan Orr, Sanku Mallik, Kenneth W. Bayles, Michael A. Hollingsworth, Amanda E. Brooks

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  8. 8

    An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. by Kaitlin M Dailey, James M Small, Jessica E Pullan, Seth Winfree, Krysten E Vance, Megan Orr, Sanku Mallik, Kenneth W Bayles, Michael A Hollingsworth, Amanda E Brooks

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  9. 9

    The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors by Kyle M. Pierce, William R. Miklavcic, Kyle P. Cook, Mikayla Sweitzer Hennen, Kenneth W. Bayles, Michael A. Hollingsworth, Amanda E. Brooks, Jessica E. Pullan, Kaitlin M. Dailey

    Published in Nanomaterials (2021-11-01)
    Get full text
    Article


  10. 10

    Quaternized chitosan derivatives inhibit growth and affect biofilm formation of Staphylococcus aureus by Alex Miranda, Nichole D. Brandquist, Kristen Johnson, Elena Muldiiarova, Aleksandr Fadeev, Mahboubeh Ghanbari, Jennifer L. Endres, Kenneth W. Bayles, Jason MacTaggart, Denis Svechkarev, Marat R. Sadykov, Yury Salkovskiy

    Published in Scientific Reports (2025-08-01)
    Get full text
    Article


  11. 11

    Catabolic Ornithine Carbamoyltransferase Activity Facilitates Growth of Staphylococcus aureus in Defined Medium Lacking Glucose and Arginine by Itidal Reslane, Cortney R. Halsey, Amanda Stastny, Barbara J. Cabrera, Jongsam Ahn, Dhananjay Shinde, Madeline R. Galac, Margaret F. Sladek, Fareha Razvi, McKenzie K. Lehman, Kenneth W. Bayles, Vinai C. Thomas, Luke D. Handke, Paul D. Fey

    Published in mBio (2022-06-01)
    Get full text
    Article


  12. 12

    Bromelain inhibits SARS‐CoV‐2 infection via targeting ACE‐2, TMPRSS2, and spike protein by Satish Sagar, Ashok Kumar Rathinavel, William E. Lutz, Lucas R. Struble, Surender Khurana, Andy T. Schnaubelt, Nitish Kumar Mishra, Chittibabu Guda, Nicholas Y. Palermo, Mara J. Broadhurst, Tobias Hoffmann, Kenneth W. Bayles, St. Patrick M. Reid, Gloria E. O. Borgstahl, Prakash Radhakrishnan

    Published in Clinical and Translational Medicine (2021-02-01)
    Get full text
    Article


Search Tools: